[1]
L. Zhang and J. Chen, “Clinical lasting response of crizotinib in ALK positive lung squamous cell carcinoma with brain metastasis”, Eur J Oncol Env Hea, vol. 22, no. 2, pp. 95–97, Nov. 2017, Accessed: Feb. 23, 2025. [Online]. Available: https://mattioli1885journals.com/index.php/EJOEH/article/view/4800